MHC class I-presented tumor antigen appraisable for T-cell responses against ovarian cancer
The purpose of this study is to assess whether MHC class I-presented tumor antigen is appraisable for T-cell responses against ovarian cancer. In ovarian cancer cell, human leukocyte antigen A2 (HLA-A2) associated with peptides was used to promote the activation of naive T cells so as to activate an...
| Published in: | Bangladesh Journal of Pharmacology |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Bangladesh Pharmacological Society
2015-07-01
|
| Subjects: | |
| Online Access: | https://www.banglajol.info/index.php/BJP/article/view/23076 |
